NetworkNewsBreaks

ThursdayMay 16, 2024 1:02 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases FY 2023 Financial Results, Provides Business Update

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices business unit, is reporting its full-year financial results for 2023 along with a company update. Highlights of the report included news that, in the first four months of 2024, the company has received CDMO work orders valued at approximately $500,000, with current guidance for this year of approximately $1.25 million in expected revenues. The report also noted that the company is “aggressively advancing” its NanoAb preclinical development, with promising results obtained in a…

Continue Reading

ThursdayMay 16, 2024 12:59 pm

NetworkNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Capitalizing on World’s Ambitions for Carbon-Neutral Future

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), a Calgary-based Canadian natural resource development and exploration company, has sought to cater to the ongoing energy transition through the exploration and development of high-grade nickel sulfide developments. “Forecasts suggest that by 2040, electric vehicles (‘EVs’) will comprise over 50% of annual passenger vehicles sales, as manufacturers and customers transition to cleaner forms of transportation in a bid to limit and curb the harmful emissions currently contributing to global warming. In turn, the surge in electric vehicle manufacturing and sales have significantly escalated the demand for crucial raw material inputs such as…

Continue Reading

ThursdayMay 16, 2024 10:55 am

NetworkNewsBreaks – Splash Beverage Group Inc. (NYSE American: SBEV) CEO Shares Shareholder Letter, Corporate Update

Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, and its chair and CEO Robert Nistico have released a letter to shareholders. In the letter, Nistico shared information from the company’s first-quarter 2024 results, along with a corporate update. Notable numbers from the quarter include sales of $1.2 million from the company’s branded beverage division, down from $1.9 million over the same period last year, with the company’s eCommerce division, Qplash, reporting shipments “well below” demand and capabilities. Nistico provided an explanation for the lower numbers, noting that the company reports revenue from shipments to distributors, which typically maintain…

Continue Reading

WednesdayMay 15, 2024 3:45 pm

NetworkNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Journeys Toward Creation of One-of-a-Kind Destination

Golden Triangle Ventures (OTC: GTVH) is a multifaceted consulting company that operates as a parent business pursuing ventures in the health, entertainment and technology sectors. GTVH and its entertainment division, Lavish Entertainment, are working with Cayenne Consulting on the strategic development of Destino Ranch. “Destino Ranch aims to redefine luxury entertainment and hospitality experiences. Set amid the breathtaking landscapes of the Mojave Desert, Destino Ranch will offer a unique blend of world-class entertainment, luxurious accommodations and immersive experiences. The destination location is designed to be an outdoor music and festival venue, immersive art installation and tourist attraction,” a recent article…

Continue Reading

WednesdayMay 15, 2024 3:30 pm

NetworkNewsBreaks – Why HealthLynked Corp. (HLYK) Is ‘One to Watch’

HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, is revolutionizing patient care through innovative digital solutions. “With a commitment to leveraging its advanced technology platforms, HealthLynked employs a sophisticated, cloud-based network that serves as a comprehensive repository for personal health data. This system not only simplifies the management and archiving of medical records but also enables the application of AI to deliver personalized healthcare insights. Through deep analysis of this data, HealthLynked’s AI capabilities help identify the root causes of diseases, tailor healthcare solutions to individual needs, and accelerate medical discoveries,” a recent article reads. “In addition to these capabilities,…

Continue Reading

WednesdayMay 15, 2024 3:00 pm

NetworkNewsBreaks – Astiva Health Reshaping Personalized and Comprehensive Healthcare Landscape

Astiva Health, a leading healthcare provider that specializes in delivering personalized and comprehensive healthcare solutions to diverse communities, has always been working on improving its provider network and physician-patient relationships, ensuring health plans align with client needs and directives. “It is this [physician-patient] partnership that Astiva is implementing in its groundbreaking approach to creating a dynamic and innovative Medicare Advantage Prescription Drug (‘MAPD’) health plan designed to reshape the landscape of personalized and comprehensive healthcare. Astiva Health provides access to experienced and dedicated providers who work together with its members to pave a pathway toward better health,” a recent article…

Continue Reading

WednesdayMay 15, 2024 2:51 pm

NetworkNewsBreaks – Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Featured in Couloir Capital Report with ‘Buy’ Recommendation

Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH), an advanced-stage, gold-exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West Gold Project, is spotlighted in a recent Couloir Capital Report. Couloir Capital is a research-driven investment dealer focused on emerging companies in the natural-resources sector. The report recommends Emperor Metals as a Buy with high risk and an initial fair market value target of $0.72. The report notes several investment highlights, including the company’s focus on expanding resource on the project through 3D modeling of resource targets and successful drilling programs and its option to acquire…

Continue Reading

WednesdayMay 15, 2024 2:22 pm

NetworkNewsBreaks – EF Hutton Collaborates with IBN to Provide Coverage, Elevate Visibility of Annual Global Conference

EF Hutton, a fast-paced, high-growth investment bank founded by experienced investment professionals, is working with IBN (“InvestorBrandNetwork”), a cutting-edge corporate communications firm and content distributor; IBN is an official media sponsor for today’s EF Hutton Annual Global Conference in New York City. As a media sponsor, IBN has focused on elevating the visibility of today’s event through amplified article syndication as well as an array of digital solutions designed increase recognition of participating companies and conference sponsors. As part of those efforts, IBN provided its audiences with summaries on each participating company and issued a special conference-focused email broadcast to subscribers of…

Continue Reading

WednesdayMay 15, 2024 2:21 pm

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Q1 2024 Results, Renews Agreement with the University of Southern California to Advance Annealing Quantum Computing Research and Adoption

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, has announced financial results for its first fiscal quarter ended March 31, 2024. Q1 revenues were up more than 50% year over year and Q1 gross profit surged 294% year over year. “We believe D-Wave’s first quarter revenue and bookings reflect growing customer demand for quantum and hybrid quantum solutions that can drive measurable impact today,” said Dr. Alan Baratz, CEO of D-Wave. “Coupled with the significant technical milestones we’ve achieved with the Advantage2™ prototype, we believe our progress leading the commercialization of quantum is…

Continue Reading

WednesdayMay 15, 2024 1:52 pm

NetworkNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces Q1 2024 Financial Results

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024. During the quarter, the company reported a loss from operations of $629,972, as compared to an operating loss of $521,258 for the comparable period in 2023. Sigyn Therapeutics’ net loss for Q1 2024 was $758,088 or $0.62 per share, as compared to a net loss of $1,341,036, or $1.39 per share, during Q1 2023. During the first quarter, SIGY completed a 1-for-40 reverse split of its common stock. As a result, 1,224,827 shares of company’s common stock are currently…

Continue Reading